Literature DB >> 21549826

Substitutes for endangered medicinal animal horns and shells exposed by antithrombotic and anticoagulation effects.

Jiaoyang Luo1, Dan Yan, Da Zhang, Xue Feng, Yan Yan, Xiaoping Dong, Xiaohe Xiao.   

Abstract

AIM OF THE STUDY: Cornu Saigae Tataricae (antelope horn), Manis Squama (pangolin scale), Cornu Cervi Pantotrichum (velvet antler) and Cornu Bovis grunniens (yak horn) are valuable medicinal animal horns and shells (MAHS). As the major source of biological agents and ethnodrugs, MAHS show pretty good bioactivities. However, with the increased demand for MAHS, some of the medicinal resources are endangered, and there has been a concomitant increase in the prevalence of adulterated or impostor MAHS. It is of great significance to exploit the substitutes for endangered medicinal animal resources. This study is going to provide a new mode for the exploitation of the substitutes of MAHS.
MATERIALS AND METHODS: Plasma recalcification time, thrombin time and thrombin consumption were recorded to evaluate the anticoagulation effect of MAHS. Dissolution rate of thrombus in vitro and whole blood-gore were observed to appraise the antithrombotic effect of MAHS.
RESULTS: All the MAHS involved in this study except Cornu Procaprae Gutturosae (argali horn), Cornu Saigae Tataricae and Cornu Bovis (cattle horn) could not only prolong recalcification time (P<0.01) and thrombin time (P<0.01), but also dissolve the thrombus in vitro (P<0.01) and whole blood-gore (P<0.01). The bioactivities among MAHS differed greatly from each other.
CONCLUSIONS: The results indicate that Cornu Caprae Hircus (goat horn), Cornu Bubali (water buffalo horn) and Trionycis Carapax (turtle shell) are rational to be explored as the substitutes of Cornu Saigae Tataricae, Cornu Bovis grunniens and Manis Squama, respectively. On the contrary, velvet antler is not suitable to be substituted by Cornu Cervi (deerhorn). We presume that the bioactive evaluation methods are effective means of seeking substitutive resources of endangered medicinal animals with the advantages of close correlation to drug action, low dosage, and high sensitiveness.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21549826     DOI: 10.1016/j.jep.2011.04.053

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  6 in total

1.  Vertebrates as a Bactericidal Agent.

Authors:  F S Ferreira; S V Brito; H D M Coutinho; E P Souza; W O Almeida; R R N Alves
Journal:  Ecohealth       Date:  2018-06-19       Impact factor: 3.184

2.  Authentication of animal signatures in traditional Chinese medicine of Lingyang Qingfei Wan using routine molecular diagnostic assays.

Authors:  Meng Cao; Jikun Wang; Lu Yao; Suhua Xie; Jing Du; Xingbo Zhao
Journal:  Mol Biol Rep       Date:  2014-01-21       Impact factor: 2.316

3.  A strategy for trade monitoring and substitution of the organs of threatened animals.

Authors:  Jiao-yang Luo; Dan Yan; Jing-yuan Song; Da Zhang; Xiao-yan Xing; Yu-mei Han; Mei-hua Yang; Xiao-ping Dong; Cheng Peng; Shi-lin Chen; Xiao-he Xiao
Journal:  Sci Rep       Date:  2013-10-31       Impact factor: 4.379

4.  Metabolomics of the Antipyretic Effects of Bubali Cornu (Water Buffalo Horn) in Rats.

Authors:  Rui Liu; Qiong Huang; Jinjun Shan; Jin-Ao Duan; Zhenhua Zhu; Pei Liu; Yong Bian; Er-Xin Shang; Dawei Qian
Journal:  PLoS One       Date:  2016-07-06       Impact factor: 3.240

5.  Available sustainable alternatives replace endangered animal horn based on their proteomic analysis and bio-effect evaluation.

Authors:  Rui Liu; Fei Wang; Qiong Huang; Jin-Ao Duan; Pei Liu; Erxin Shang; Dong Zhu; Hongmei Wen; Dawei Qian
Journal:  Sci Rep       Date:  2016-10-27       Impact factor: 4.379

Review 6.  Evidence for the medicinal value of Squama Manitis (pangolin scale): A systematic review.

Authors:  Xinyao Jin; Hui Zi Chua; Keyi Wang; Nan Li; Wenke Zheng; Wentai Pang; Fengwen Yang; Bo Pang; Mingyan Zhang; Junhua Zhang
Journal:  Integr Med Res       Date:  2020-07-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.